Cargando…
C3a Receptor Antagonist Ameliorates Inflammatory and Fibrotic Signals in Type 2 Diabetic Nephropathy by Suppressing the Activation of TGF-β/smad3 and IKBα Pathway
OBJECTIVE: Diabetic nephropathy (DN) is a serious complication for patients with diabetes mellitus (DM). Emerging evidence suggests that complement C3a is involved in the progression of DN. The aim of this study was to investigate the effect of C3a Receptor Agonist (C3aRA) on DN and its potential me...
Autores principales: | Li, Ling, Yin, Qinghua, Tang, Xi, Bai, Lin, Zhang, Jie, Gou, Shenju, Zhu, Hongping, Cheng, Jingqiu, Fu, Ping, Liu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244104/ https://www.ncbi.nlm.nih.gov/pubmed/25422985 http://dx.doi.org/10.1371/journal.pone.0113639 |
Ejemplares similares
-
All-Trans Retinoic Acid Attenuates Fibrotic Processes by Downregulating TGF-β1/Smad3 in Early Diabetic Nephropathy
por: Sierra-Mondragon, Edith, et al.
Publicado: (2019) -
Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway
por: Wang, Dongdong, et al.
Publicado: (2018) -
Pembrolizumab induced-C3 glomerulonephritis and RBC cast nephropathy: a case report
por: Yang, Zhi, et al.
Publicado: (2023) -
Petchiether A attenuates obstructive nephropathy by suppressing TGF‐β/Smad3 and NF‐κB signalling
por: You, Yong‐Ke, et al.
Publicado: (2019) -
Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways
por: Ren, Qian, et al.
Publicado: (2022)